CD163 and neoplasm: Although LMO7 did not promote an increase in the percentages of CD3+ T cells, CD3+ CD8+ T cells, CD163+ macrophages, GranzymeB+ cells, and CD3+ FOXP3+ T cells among all nucleated cells, it induced Treg and dysfunctional CD8+ T cells to be in closer proximity to tumor cells.